muscimol has been researched along with n(6)-cyclopentyladenosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, S; Furuya, K; Hida, H; Ikenaka, K; Lee, HU; Miyakawa, T; Sokabe, M; Takao, K; Tanaka, KF; Yamazaki, Y | 1 |
1 other study(ies) available for muscimol and n(6)-cyclopentyladenosine
Article | Year |
---|---|
Increased astrocytic ATP release results in enhanced excitability of the hippocampus.
Topics: Adenosine; Adenosine Triphosphate; Animals; Astrocytes; Biophysical Phenomena; Cells, Cultured; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; GABA-A Receptor Agonists; Glial Fibrillary Acidic Protein; Hippocampus; Humans; In Vitro Techniques; Long-Term Potentiation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microdialysis; Muscimol; Mutation; Neurons; Patch-Clamp Techniques; Phosphinic Acids; Propanolamines; Purinergic P1 Receptor Antagonists | 2013 |